SingleQuotsTM Kit for adipogenic differentiation of mesenchymal stem cells
Cryopreserved ampule of Human Peripheral Blood CD4+ T Cells containing ≥10 million cells, negatively selected.
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Bone Marrow Mononuclear Cells containing ≥25 million cells
Cryopreserved ampule of Normal Human Bronchial Epithelial (NHBE) cells with Retinoic Acid containing ≥500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, cultured in EGMTM-2, pre-screened for Angiogenesis and containing ≥ 500,000 cells
Yearly guarantee extension for the 96-well Shuttle® System that can be purchased together with the system or as long as the system is covered by an existing guarantee.
Please note that this product is no longer available for purchase. The 96-well Shuttle® has been replaced by the new 4D-Nucleofector® 96-well Unit.
Cryopreserved ampule of Mouse C57 Mixed Astrocytes containing ≥ 1 million cells
Yearly guarantee extension for the LucettaTM 2 Luminometer that can be purchased together with the instrument or as long as the instrument is covered by an existing guarantee.
-
References - X-Vivo™Overview of relevant references
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
TechSheet - X-VIVO™ Media SystemsInstructions for how to use the X-VIVO™ Media Series
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Non-viral Gene Modification for Ex-vivo Cell TherapyIn this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
-
Terms and Conditions TheraPEAK T-VIVO Sample Request Program
-
4D-Nucleofector® LV Unit for Large-scale TransfectionEfficient, closed and scalable transfection for ex vivo cell and gene therapy applications
-
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
-
Clonetics™ and Poietics™ Disease CellsIn Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal